|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.81 USD | +0.22% |
|
+0.36% | -14.54% |
Chart calendar Legend Biotech Corporation
Upcoming events on Legend Biotech Corporation
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #92 | Add to your calendar Google Apple ICS format |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #94 | Add to your calendar Google Apple ICS format |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #266 | Add to your calendar Google Apple ICS format |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #2214 | Add to your calendar Google Apple ICS format |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #2411 | Add to your calendar Google Apple ICS format |
| 06/12/2025 | American Society of Hematology Meeting - Abstract No - #2215 | Add to your calendar Google Apple ICS format |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #4046 | Add to your calendar Google Apple ICS format |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #3992 | Add to your calendar Google Apple ICS format |
| 07/12/2025 | American Society of Hematology Meeting - Abstract No - #4596 | Add to your calendar Google Apple ICS format |
| 08/12/2025 | American Society of Hematology Meeting - Abstract No - #5768 | Add to your calendar Google Apple ICS format |
| 17/03/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 18/05/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 17/08/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 16/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Legend Biotech Corporation
| 12/11/2025 | Q3 2025 Earnings Call |
| 12/11/2025 | Q3 2025 Earnings Release |
| 09/09/2025 | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 11/08/2025 | Q2 2025 Earnings Call |
| 11/08/2025 | Q2 2025 Earnings Release |
| 14/06/2025 | European Hematology Association Congress - Abstract No: #PS1723 |
| 14/06/2025 | European Hematology Association Congress - Abstract No: #PS1728 |
| 13/06/2025 | European Hematology Association Congress - Abstract No: #PF765 |
| 12/06/2025 | European Hematology Association Congress - Abstract No: #S192 |
| 12/06/2025 | Annual General Meeting |
| 03/06/2025 | American Society of Clinical Oncology Meeting - Abstract No : #7507 |
| 02/06/2025 | American Society of Clinical Oncology Meeting |
| 01/06/2025 | American Society of Clinical Oncology Meeting - Abstract No : #7539 |
| 31/05/2025 | American Society of Clinical Oncology Meeting - Abstract No : #8104 |
| 31/05/2025 | American Society of Clinical Oncology Meeting - Abstract No : #4022 |
| 16/05/2025 | American Society of Gene & Cell Therapy Meeting - Abstract No : #339 |
| 13/05/2025 | Q1 2025 Earnings Call |
| 13/05/2025 | Q1 2025 Earnings Release |
| 11/03/2025 | Q4 2024 Earnings Call |
| 11/03/2025 | Q4 2024 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 117 132 -11.08% | 285 296 -3.82% | 627 616 1.87% | 1 037 | 1 567 | 2 078 |
|
EBITDA Million USD | Released Forecast Spread | -443 -305 -45.35% | -392 -420 6.65% | -113 -269 57.98% | -104 | 249 | 602 |
|
EBIT Million USD | Released Forecast Spread | -456 -424 -7.4% | -413 -458 9.85% | -137 -286 52.29% | -156 | 197 | 567 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -446 -437 -1.97% | -520 -487 -6.75% | -158 -277 42.94% | -252 | 164 | 530 |
|
Net income Million USD | Released Forecast Spread | -446 -437 -2.06% | -518 -482 -7.55% | -177 -280 36.85% | -258 | 141 | 491 |
|
EPS USD | Released Forecast Spread | -2,80 -2,79 -0.36% | -2,94 -2,84 -3.57% | -0,96 -1,32 27.12% | -0,84 | 0,54 | 1,22 |
| Announcement Date | 30/03/23 | 11/03/24 | 11/03/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 94,0 141 -33.51% | 187 126 47.91% | 160 146 9.67% | 187 179 4.2% | 195 194 0.61% | 255 228 11.85% | 272 275 -1.11% | 318 | 332 | 367 | 393 | 437 | 523 | 523 | 523 |
|
EBITDA Million USD | Released Forecast Spread | -48,6 -77,4 37.24% | -36,6 -101 63.85% | -110 -101 -9.25% | 52,5 -110 147.69% | -88,9 -65,2 -36.22% | -16,0 -57,1 71.92% | -27,6 -15,7 -75.91% | -9,66 | |||||||
|
EBIT Million USD | Released Forecast Spread | -54,3 -63,1 13.98% | -42,0 -89,0 52.86% | -115 -101 -14.47% | 45,7 -72,8 162.75% | -94,1 -77,1 -22.08% | -120 -40,2 -197.35% | -33,4 -26,8 -24.64% | -29,8 | |||||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -59,8 -69,7 14.2% | -18,0 -85,4 78.95% | -121 -98,8 -22.38% | 40,5 -87,3 146.42% | -99,1 -72,7 -36.4% | -125 -39,9 -212.95% | -39,1 -18,7 -109.16% | -15,9 | -2,58 | 14,4 | 24,1 | 41,3 | 94,2 | 94,7 | 95,3 |
|
Net income Million USD | Released Forecast Spread | -59,8 -69,4 13.89% | -18,2 -92,3 80.29% | -125 -98,9 -26.71% | 26,3 -85,9 130.61% | -101 -72,6 -38.93% | -125 -38,2 -228.51% | -39,7 -21,9 -81.06% | -17,2 | -3,44 | 13,4 | 23,1 | 40,1 | 94,2 | 94,7 | 95,3 |
|
EPS USD | Released Forecast Spread | -0,32 -0,32 -1.59% | -0,10 -0,45 77.78% | -0,68 -0,58 -17.24% | 0,14 -0,41 134.15% | -0,54 -0,26 -107.69% | -0,68 -0,21 -231.71% | -0,22 -0,11 -101.35% | -0,08 | -0,04 | 0,07 | 0,10 | 0,21 | |||
| Announcement Date | 13/05/24 | 09/08/24 | 12/11/24 | 11/03/25 | 13/05/25 | 11/08/25 | 12/11/25 | - | - | - | - | - | - | - | - |
| 14/12/2025 | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 14/01/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 10/02/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Legend Biotech Corporation
| 03/12/2025 | Q2 2026 Earnings Release (Projected) | |
| 25/11/2025 | Q4 2025 Earnings Release | |
| 21/11/2025 | Q3 2025 Sales and Revenue Release | |
| 17/11/2025 | Q3 2025 Earnings Release | |
| 14/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release | |
| 13/11/2025 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LEGN Stock
- Calendar Legend Biotech Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















